Literature DB >> 9676851

Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer.

H C Wirtz1, W Müller, T Noguchi, M Scheven, J Rüschoff, G Hommel, H E Gabbert.   

Abstract

In this study, microsatellite instability (MI) was investigated in 126 gastric carcinomas and correlated with clinicopathological features and prognosis; at least 5-10 microsatellite loci were analyzed. MI was identified in 56 (44.5%) of all investigated carcinomas, one locus being affected in 40 (31.7%) carcinomas, two loci being affected in 6 (4.8%) carcinomas, and more than two loci being affected in 10 (8.0%) carcinomas. MI was correlated with neither age and sex of the patients nor with depth of invasion, lymph node metastasis, tumor differentiation, or histological type according to WHO and Laurén classification. The frequency of MI was the same in early gastric carcinomas as it was in advanced gastric carcinomas, suggesting that MI arises early during the tumorigenesis of gastric cancer. No significant differences in survival could be demonstrated between patients with MI-negative and MI-positive gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9676851

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  24 in total

1.  Detection of microsatellite instability in gastric cancer and dysplasia tissues.

Authors:  Bing Li; Hong-Yi Liu; Shao-Hua Guo; Peng Sun; Fang-Ming Gong; Bao-Qing Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Primary squamous cell carcinoma of the endometrium unrelated to human papilloma virus: a molecular study.

Authors:  Giovanna Giordano; Silvia Pizzi; Cinzia Azzoni; Lorena Bottarelli; Tiziana D'Adda
Journal:  Pathol Oncol Res       Date:  2013-02-21       Impact factor: 3.201

4.  Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population.

Authors:  A R Conde; G Martins; C Saraiva; J Rueff; C Monteiro
Journal:  Mol Pathol       Date:  1999-06

5.  Origin of microsatellite instability in gastric cancer.

Authors:  K C Halling; J Harper; C A Moskaluk; S N Thibodeau; G R Petroni; A S Yustein; P Tosi; C Minacci; F Roviello; P Piva; S R Hamilton; C E Jackson; S M Powell
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  Two cases of low-grade endometriod carcinoma associated with undifferentiated carcinoma of the uterus (dedifferentiated carcinoma): a molecular study.

Authors:  Giovanna Giordano; Tiziana D'Adda; Lorena Bottarelli; Mariano Lombardi; Francesca Brigati; Roberto Berretta; Carla Merisio
Journal:  Pathol Oncol Res       Date:  2011-03-30       Impact factor: 3.201

7.  Microsatellite instability in gastric cancer and pre-cancerous lesions.

Authors:  Ping Liu; Xiao-Yong Zhang; Yun Shao; Dao-Fu Zhang
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

8.  Microsatellite instability and survival in gastric cancer: A systematic review and meta-analysis.

Authors:  Lin Zhu; Zhi Li; Yan Wang; Chenlu Zhang; Yunpeng Liu; Xiujuan Qu
Journal:  Mol Clin Oncol       Date:  2015-02-06

9.  Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.

Authors:  Adriana Camargo Ferrasi; Nídia Alice Pinheiro; Silvia Helena Barem Rabenhorst; Otávia Luisa Caballero; Maria Aparecida Marchesan Rodrigues; Fabrício de Carvalho; Celso Vieira de Souza Leite; Marcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês Moura Campos Pardini
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

10.  Studies on microsatellite instability in p16 gene and expression of hMSH2 mRNA in human gastric cancer tissues.

Authors:  Qin-Xian Zhang; Yi Ding; Xiao-Ping Le; Peng Du
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.